VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TEMTempus AI, Inc.
$50.84$8.9B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

TEM logoTempus AI, Inc.(TEM)Earnings, Financials & Key Ratios

TEM•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryLife Sciences and Precision Medicine Software
AboutTempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.Show more
  • Revenue$1.27B+83.4%
  • EBITDA-$235M+64.1%
  • Net Income-$245M+65.3%
  • EPS (Diluted)-1.41+69.3%
  • Gross Margin69.64%+26.7%
  • EBITDA Margin-18.44%+80.4%
  • Operating Margin-18.76%+81.2%
  • Net Margin-19.27%+81.1%
  • ROE-89.48%+92.9%

TEM Key Insights

Tempus AI, Inc. (TEM) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 46.6%

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 18.0x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when TEM posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

TEM Price & Volume

Tempus AI, Inc. (TEM) stock price & volume — 10-year historical chart

Loading chart...

TEM Growth Metrics

Tempus AI, Inc. (TEM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years46.57%
3 Years58.29%
TTM69.82%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM57.28%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM62.61%

Return on Capital

10 Years-56.33%
5 Years-63.6%
3 Years-70.52%
Last Year-18.81%

TEM Recent Earnings

Tempus AI, Inc. (TEM) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (75%)●Beat Revenue 6/12 qtrs (75%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.13+38.1%
$0.21
Rev
$348M+0.8%
$345M
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.04+8.8%
$0.04
Rev
$367M+1.3%
$363M
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$0.11+36.2%
$0.17
Rev
$334M+1.7%
$329M
Q3 2025
Aug 8, 2025
Metric
Actual
Est
EPS
$0.22+4.3%
$0.23
Rev
$315M+5.7%
$298M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.13vs $0.21+38.1%
$348Mvs $345M+0.8%
Q1 2026Feb 24, 2026
$0.04vs $0.04+8.8%
$367Mvs $363M+1.3%
Q4 2025Nov 4, 2025
$0.11vs $0.17+36.2%
$334Mvs $329M+1.7%
Q3 2025Aug 8, 2025
$0.22vs $0.23+4.3%
$315Mvs $298M+5.7%
Based on last 12 quarters of dataView full earnings history →

TEM Peer Comparison

Tempus AI, Inc. (TEM) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
EXAS logoEXASExact Sciences CorporationDirect Competitor20.02B104.91-95.3717.69%-6.4%-8.66%1.05
NTRA logoNTRANatera, Inc.Direct Competitor33.14B231.41-152.2435.9%-9.05%-15.13%0.13
VCYT logoVCYTVeracyte, Inc.Direct Competitor4.28B53.6365.4016.01%16.25%6.86%0.03
FLGT logoFLGTFulgent Genetics, Inc.Direct Competitor535.45M18.00-9.1413.83%-18.75%-5.42%0.00
ILMN logoILMNIllumina, Inc.Product Competitor24.6B161.9329.71-0.78%19.43%32.84%0.94
PACB logoPACBPacific Biosciences of California, Inc.Product Competitor434.84M1.40-0.773.89%-80.34%-488.45%141.98
CDNA logoCDNACareDx, IncProduct Competitor1.35B26.18-65.4513.79%-1.98%-2.61%0.06
ORCL logoORCLOracle CorporationSupply Chain530.08B184.3131.6117.35%25.37%49.81%3.63

Compare TEM vs Peers

Tempus AI, Inc. (TEM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs EXAS

Most directly comparable listed peer for TEM.

Scale Benchmark

vs ORCL

Larger-name benchmark to compare TEM against a more recognizable public peer.

Peer Set

Compare Top 5

vs EXAS, NTRA, VCYT, FLGT

TEM Income Statement

Tempus AI, Inc. (TEM) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
62.06M188M257.85M320.67M531.82M693.4M1.27B1.36B
Revenue Growth %
-202.95%37.15%24.36%65.85%30.38%83.41%69.82%
Cost of Goods Sold
46.02M159.29M174.21M190.48M245.65M312.29M386.1M386.53M
COGS % of Revenue
74.15%84.73%67.56%59.4%46.19%45.04%30.36%-
Gross Profit
16.04M▲ 0%
28.71M▲ 79.0%
83.64M▲ 191.3%
130.19M▲ 55.6%
286.18M▲ 119.8%
381.11M▲ 33.2%
885.69M▲ 132.4%
977.64M▲ 0%
Gross Margin %
25.85%15.27%32.44%40.6%53.81%54.96%69.64%71.67%
Gross Profit Growth %
-78.99%191.3%55.64%119.82%33.17%132.39%-
Operating Expenses
135.82M222.17M327.36M395.63M482.26M1.07B1.12B1.23B
OpEx % of Revenue
218.87%118.17%126.95%123.38%90.68%154.63%88.4%-
Selling, General & Admin
78.96M130.89M199M233.38M296.76M755.35M731.74M784.62M
SG&A % of Revenue
127.24%69.62%77.18%72.78%55.8%108.93%57.54%-
Research & Development
56.86M91.28M128.35M162.25M185.5M316.84M146.11M276.99M
R&D % of Revenue
91.63%48.55%49.78%50.6%34.88%45.69%11.49%-
Other Operating Expenses
000000246.48M2M
Operating Income
-119.78M▲ 0%
-193.45M▼ 61.5%
-243.71M▼ 26.0%
-265.44M▼ 8.9%
-196.08M▲ 26.1%
-691.08M▼ 252.4%
-238.63M▲ 65.5%
-254.66M▲ 0%
Operating Margin %
-193.02%-102.9%-94.52%-82.78%-36.87%-99.67%-18.76%-18.67%
Operating Income Growth %
--61.51%-25.98%-8.92%26.13%-252.44%65.47%-
EBITDA
-104.76M-170.4M-219.83M-235.03M-162.75M-653.84M-234.55M-270.92M
EBITDA Margin %
-168.81%-90.64%-85.25%-73.29%-30.6%-94.29%-18.44%-19.86%
EBITDA Growth %
--62.66%-29.01%-6.92%30.75%-301.74%64.13%58.83%
D&A (Non-Cash Add-back)
15.02M23.05M23.88M30.41M33.33M37.24M4.09M-16.27M
EBIT
-114.92M-192.43M-243.4M-267.26M-166.66M-647.66M-226.44M-216.82M
Net Interest Income
4.83M-17.43M-14.56M-18.86M-39.27M-42.57M-57.64M-126.05M
Interest Income
4.86M1.5M623K3.03M7.6M11.08M12.63M14.68M
Interest Expense
28K18.93M15.18M21.89M46.87M53.65M70.27M122.52M
Other Income/Expense
4.83M-16.4M-15.48M-24.3M-17.75M-14.46M-58.08M-50.73M
Pretax Income
-114.95M▲ 0%
-209.85M▼ 82.6%
-259.19M▼ 23.5%
-289.75M▼ 11.8%
-213.83M▲ 26.2%
-705.54M▼ 230.0%
-296.71M▲ 57.9%
-305.39M▲ 0%
Pretax Margin %
-185.23%-111.62%-100.52%-90.36%-40.21%-101.75%-23.33%-22.39%
Income Tax
00066K288K266K-51.68M-5.44M
Effective Tax Rate %
0%0%0%-0.02%-0.13%-0.04%17.42%1.78%
Net Income
-114.95M▲ 0%
-209.85M▼ 82.6%
-259.19M▼ 23.5%
-289.81M▼ 11.8%
-214.12M▲ 26.1%
-705.81M▼ 229.6%
-245.03M▲ 65.3%
-302.91M▲ 0%
Net Margin %
-185.23%-111.62%-100.52%-90.38%-40.26%-101.79%-19.27%-22.2%
Net Income Growth %
--82.56%-23.51%-11.81%26.12%-229.64%65.28%57.28%
Net Income (Continuing)
-114.95M-209.85M-259.19M-289.81M-214.12M-705.81M-245.03M-302.91M
Discontinued Operations
00000000
Minority Interest
00000000
EPS (Diluted)
-0.92▲ 0%
-1.49▼ 62.0%
-1.75▼ 17.4%
-1.97▼ 12.6%
-1.73▲ 12.2%
-4.60▼ 165.9%
-1.41▲ 69.3%
-1.69▲ 0%
EPS Growth %
--61.96%-17.45%-12.57%12.18%-165.9%69.35%62.61%
EPS (Basic)
-0.92-1.49-1.75-1.97-1.73-4.60-1.41-
Diluted Shares Outstanding
160.71M169.88M169.88M169.88M154.17M162.12M174.26M178.96M
Basic Shares Outstanding
160.71M169.88M169.88M169.88M154.17M162.12M174.26M178.88M
Dividend Payout Ratio
--------

TEM Balance Sheet

Tempus AI, Inc. (TEM) balance sheet — assets, liabilities & shareholders' equity

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
276.23M649.73M403.99M438.63M350.33M667.6M1.17B1.05B
Cash & Short-Term Investments
227.6M513.44M277.69M302.94M197.57M448.26M755M639.07M
Cash Only
227.6M513.44M277.69M302.94M165.77M340.95M604.79M521.17M
Short-Term Investments
000031.81M107.31M150.21M117.9M
Accounts Receivable
31.89M87.26M82.24M88.68M94.46M154.82M311.17M308.6M
Days Sales Outstanding
187.56169.41116.42100.9464.8381.589.378.74
Inventory
8.28M37.56M22.91M22.28M28.84M38.39M51.72M51.83M
Days Inventory Outstanding
65.6786.064842.742.8644.8748.948.66
Other Current Assets
8.47M11.48M21.15M24.73M29.45M26.14M49.28M54.44M
Total Non-Current Assets
93.94M102.19M127.37M192.74M213.72M258.51M1.11B1.08B
Property, Plant & Equipment
36.06M38.44M35.4M67.79M82.21M72.82M153.65M150.9M
Fixed Asset Turnover
1.72x4.89x7.29x4.73x6.47x9.52x8.28x9.20x
Goodwill
15.99M15.99M15.98M53.1M73.35M73.34M470.21M470.17M
Intangible Assets
41.33M44.46M37.29M37.28M21.92M11.72M355.25M330.59M
Long-Term Investments
0000091.45M21.11M236.36M
Other Non-Current Assets
558K3.3M38.7M34.57M36.24M9.19M107.44M108.96M
Total Assets
370.17M▲ 0%
751.92M▲ 103.1%
531.35M▼ 29.3%
631.36M▲ 18.8%
564.05M▼ 10.7%
926.12M▲ 64.2%
2.27B▲ 145.6%
2.14B▲ 0%
Asset Turnover
0.17x0.25x0.49x0.51x0.94x0.75x0.56x0.66x
Asset Growth %
-103.13%-29.33%18.82%-10.66%64.19%145.63%406.76%
Total Current Liabilities
43.73M101.38M114.81M174.24M232.63M291.07M372.39M317.96M
Accounts Payable
13.41M53.57M33.75M45.99M54.42M53.8M81.99M41.02M
Days Payables Outstanding
106.41122.7570.7288.1280.8662.8977.5161.83
Short-Term Debt
00000013.36M12.64M
Deferred Revenue (Current)
5.57M6.96M16.45M50.14M64.86M91.94M92.67M382.64M
Other Current Liabilities
5.72M14.01M22.33M24.73M30.16M31.73M184.37M191.43M
Current Ratio
6.32x6.41x3.52x2.52x1.51x2.29x3.13x3.31x
Quick Ratio
6.13x6.04x3.32x2.39x1.38x2.16x3.00x3.15x
Cash Conversion Cycle
146.82132.7193.755.5226.8363.4860.6965.58
Total Non-Current Liabilities
580.85M1.16B1.22B1.59B1.71B578.71M1.41B1.4B
Long-Term Debt
0250M238.24M389.55M449.67M435.44M802.35M801.99M
Capital Lease Obligations
1.44M724K291K37.13M32.04M26.2M0123.59M
Deferred Tax Liabilities
00000000
Other Non-Current Liabilities
579.41M912.8M985.51M1.12B1.22B86.43M608.77M598.74M
Total Liabilities
624.59M1.26B1.34B1.76B1.95B869.78M1.78B1.72B
Total Debt
2.59M251.45M238.95M433.03M488.14M468.09M815.71M814.63M
Net Debt
-225.01M-261.99M-38.74M130.09M322.38M127.14M210.92M293.46M
Debt / Equity
-----8.31x1.66x1.96x
Debt / EBITDA
--------3.01x
Net Debt / EBITDA
--------1.08x
Interest Coverage
-4104.39x-10.17x-16.03x-12.21x-3.56x-12.07x-3.22x-1.77x
Total Equity
-254.41M▲ 0%
-512.98M▼ 101.6%
-807.49M▼ 57.4%
-1.13B▼ 39.8%
-1.38B▼ 22.4%
56.34M▲ 104.1%
491.33M▲ 772.1%
416.4M▲ 0%
Equity Growth %
--101.63%-57.41%-39.82%-22.42%104.08%772.09%1859.99%
Book Value per Share
-1.58-3.02-4.75-6.65-8.960.352.822.33
Total Shareholders' Equity
-254.41M-512.98M-807.49M-1.13B-1.38B56.34M491.33M416.4M
Common Stock
6K6K6K6K6K17K00
Retained Earnings
-257.85M-512.99M-807.49M-1.14B-1.4B-2.15B00
Treasury Stock
0000-3.6M-3.6M00
Accumulated OCI
1K-1K-11K18K5K94K00
Minority Interest
00000000

TEM Cash Flow Statement

Tempus AI, Inc. (TEM) cash flow — operating, investing & free cash flow history

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-117.11M-206.56M-211.98M-168.2M-214.34M-189.04M-218.09M-185.74M
Operating CF Margin %
-188.72%-109.87%-82.21%-52.45%-40.3%-27.26%-17.15%-
Operating CF Growth %
--76.38%-2.62%20.65%-27.43%11.8%-15.36%-163.87%
Net Income
-114.95M-209.85M-259.19M-289.81M-214.12M-705.81M-245.03M-302.91M
Depreciation & Amortization
15.02M23.05M23.88M30.41M33.33M37.24M4.09M84.93M
Stock-Based Compensation
529K399K559K00534.14M124.75M154.48M
Deferred Taxes
000000-52.66M-6.45M
Other Non-Cash Items
3.65M15.29M8.22M19.38M4.28M-16.82M129.31M-61.3M
Working Capital Changes
-21.36M-35.45M14.55M71.82M-37.84M-37.8M-178.55M-54.49M
Change in Receivables
-13.37M-55.84M4.75M-8.2M-7.35M-61.04M-90.4M-43.24M
Change in Inventory
-3.47M-29.28M14.65M-1.31M-6.56M-9.54M-3.37M-2.79M
Change in Payables
038.13M-30.47M-7.92M-23.36M-23.85M-7.24M-55.81M
Cash from Investing
-43.03M-13.42M-21.72M-57.94M-40.31M-130.39M-398.36M-22.54M
Capital Expenditures
-17.04M-13.42M-11.77M-18.38M-34.61M-22.12M-27.27M-18.98M
CapEx % of Revenue
27.45%7.14%4.56%5.73%6.51%3.19%2.14%1.39%
Acquisitions
-25.99M0-5.96M-39.56M-5.71M-95.19M-376.67M4.1M
Investments
--------
Other Investing
00-4M0000-4.92M
Cash from Financing
196.69M506.11M-2.04M251.39M117.55M494.33M884.12M591.08M
Debt Issued (Net)
-919K329.11M-796K170.25M82.59M0735.76M726.5M
Equity Issued (Net)
202.9M182.62M8.89M92.2M41.28M579.45M192.46M-3.04M
Dividends Paid
-5.29M-5.63M-5.63M-5.63M-5.63M-5.63M00
Share Repurchases
0-7.31M00-3.6M0-3.04M-3.04M
Other Financing
00-4.51M-5.43M-698K-79.5M-44.1M-132.38M
Net Change in Cash
36.54M▲ 0%
286.12M▲ 682.9%
-235.75M▼ 182.4%
25.27M▲ 110.7%
-137.12M▼ 642.7%
175.23M▲ 227.8%
263.83M▲ 50.6%
456.13M▲ 0%
Free Cash Flow
-134.15M▲ 0%
-219.98M▼ 64.0%
-223.75M▼ 1.7%
-186.58M▲ 16.6%
-248.95M▼ 33.4%
-211.17M▲ 15.2%
-239.14M▼ 13.2%
-208.3M▲ 0%
FCF Margin %
-216.17%-117.01%-86.77%-58.19%-46.81%-30.45%-18.8%-15.27%
FCF Growth %
--63.98%-1.72%16.61%-33.43%15.18%-13.25%2.06%
FCF per Share
-0.83-1.29-1.32-1.10-1.61-1.30-1.37-1.16
FCF Conversion (FCF/Net Income)
1.02x0.98x0.82x0.58x1.00x0.27x0.89x0.69x
Interest Paid
02.05M80K4.66M16.91M28.05M026.5M
Taxes Paid
08K3K6K161K206K0136K

TEM Key Ratios

Tempus AI, Inc. (TEM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)
-----1252.79%-89.48%-70.24%
Return on Invested Capital (ROIC)
-----282.49%-40.41%-21.36%
Gross Margin
15.27%32.44%40.6%53.81%54.96%69.64%71.67%
Net Margin
-111.62%-100.52%-90.38%-40.26%-101.79%-19.27%-22.2%
Debt / Equity
----8.31x1.66x1.96x
Interest Coverage
-10.17x-16.03x-12.21x-3.56x-12.07x-3.22x-1.77x
FCF Conversion
0.98x0.82x0.58x1.00x0.27x0.89x0.69x
Revenue Growth
202.95%37.15%24.36%65.85%30.38%83.41%69.82%
Related:TEM Dividend History·TEM Revenue History·TEM Price History·TEM P/E History·TEM Financial Ratios·TEM Institutional Holders

TEM SEC Filings & Documents

Tempus AI, Inc. (TEM) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 24, 2026·SEC

Material company update

Jan 12, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 24, 2025·SEC

10-Q Quarterly Reports

4
FY 2026

May 5, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 8, 2025·SEC

TEM Frequently Asked Questions

Tempus AI, Inc. (TEM) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Tempus AI, Inc. (TEM) reported $1.36B in revenue for fiscal year 2025. This represents a 2098% increase from $62.1M in 2019.

Tempus AI, Inc. (TEM) grew revenue by 83.4% over the past year. This is strong growth.

Tempus AI, Inc. (TEM) reported a net loss of $302.9M for fiscal year 2025.

Dividend & Returns

Tempus AI, Inc. (TEM) has a return on equity (ROE) of -89.5%. Negative ROE indicates the company is unprofitable.

Tempus AI, Inc. (TEM) had negative free cash flow of $208.3M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in TEM back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

How much would $100/month in TEM be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →